GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Polymeric Biomaterials Market, By Product (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethanes, Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK), Polydioxanone (PDO) and Others), By Application (Cardiovascular (Bioresorbable Stents, Vascular Grafts, Sensors, Guidewires, Implantable Cardiac Defibrillators, Pacemakers, and Others), Dental (Tissue Regeneration Materials, Dental Implants, Bone Grafts & Substitutes, Dental Membranes, Dental Sutures and Others), Orthopedic (Joint Replacement Polymeric Biomaterials, Tissue Fixation Products (Suture Anchors and Others), Orthobiologics, Viscosupplementation, Spine Biomaterials and Others), Plastic Surgery (Facial Wrinkle Treatment, Soft Tissue Fillers, Craniofacial Surgery (Sutures and Others), Bioengineered Skins, Peripheral Nerve Repair, Acellular Dermal Matrices and Others), Neurology (Neural Stem Cell Encapsulation, Shunting Systems, Hydrogel Scaffold For CNS Repair, Cortical Neural Prosthetics and Others) and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Polymeric Biomaterials Market- Recent Developments

Product and Technology Launch

On March 8, 2023, Invibio Ltd., a medical device company made waves with the introduction of its PEEK-OPTIMA AM filament. This product is specifically designed for the additive manufacturing sector within the medical device industry, offering optimized performance and precision.
On January 2023, MicroPort Scientific Corporation, a medical device company celebrated a significant milestone with the acquisition of marketing authorization for its firehawk liberty rapamycin target eluting coronary stent system within the Russian market.

Business Development Activities by the Market Players

On February 27, 2023, Victrex plc. the parent company of Invibio Ltd., publicized the expansion of Invibio's R&D and production capabilities that is dedicated to medical advancements. This expansion was marked by the inauguration of their new product development facility located in Leeds, U.K.